Active Biotech Gets International Order for Cholera Vaccine After Recommendation From WHO.LUND, Sweden--(BUSINESS WIRE)--August 6, 1999-- Active Biotech's subsidiary SBL SBL Society of Biblical Literature SBL Symbol Technologies, Inc. (NYSE symbol) SBL Spamhaus Block List SBL Space-Based Laser SBL Securities Borrowing and Lending SBL Supreme Beings of Leisure (band) Vaccin has received its first big international order for its oral vaccine against cholera cholera (kŏl`ərə) or Asiatic cholera, acute infectious disease caused by strains of the bacterium Vibrio cholerae that have been infected by bacteriophages. . The world health organisation, WHO, has established that the cholera vaccine of SBL is the only vaccine on the market with a documented high efficiency. The customer is the public health authority of Madagascar. The vaccine will be delivered in batches with the first batch delivered in July. The value of the order amounts to approx. 2 m US Dollar. Additional orders for cholera vaccine are expected later this autumn according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the authority's judgement. Cholera epidemic on Madagascar The public health authority of Madagascar needs the vaccine against the cholera epidemic that broke out earlier this year. The cholera has already spread to areas outside the capital Antananarivo. It is feared that around 200 people have died. Currently vaccination is carried out primarily on doctors and other hospital staff. Madagascar is the fourth largest island in the world with a population of approximately 15 million. WHO recommends SBL's cholera vaccine The world health organisation, WHO, has established that the Cholera vaccine SBL is the only vaccine on the market with a documented high efficiency. For the first time WHO has also expressed a recommendation for preventive cholera vaccination in the areas of the world with high risk of cholera. Cholera vaccine SBL is orally taken, which considerably facilitates a fast distribution to a large number of people in areas threatened by a cholera epidemic. Cholera vaccine SBL is the only existing cholera vaccine that has gone through field studies, among other things in Bangladesh with a total of 90 000 persons participating. The vaccine consists of the rCTB component and four strains of inactivated inactivated rendered inactive; the activity is destroyed. inactivated viruses treated so that they are no longer able to produce evidence of growth or damaging effect on tissue. cholera bacteria. SBL Vaccin produces the rCTB component and the final vaccine in its production facilities in Solna and Matfors, Sweden. The same technology as the coming ETEC ETEC enterotoxigenic Escherichia coli. ETEC Enterotoxic Escherichia coli, see there vaccine Active Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. , together with its partner SmithKline Beecham, is currently performing phase III Noun 1. phase III - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA studies of its ETEC vaccine in Kenya and Guatemala/Mexico. The clinical trials are in the final stage. The ETEC vaccine is based on the same rCTB component as the cholera vaccine but with five inactivated strains of the E.coli bacteria |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion